November 18, 1999Open Access

Antitumor Activity of Thalidomide in Refractory Multiple Myeloma

Key Points

Key points are not available for this paper at this time.

Abstract

Thalidomide is active against advanced myeloma. It can induce marked and durable responses in some patients with multiple myeloma, including those who relapse after high-dose chemotherapy.

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Discussion

Authors

Seema Singhal

Jayesh Mehta

Raman Desikan

Journals

New England Journal of Medicine

Actions

Institutions

Rockefeller University

University of South Carolina

University of Arkansas for Medical Sciences

References and Citations

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Antitumor Activity of Thalidomide in Refractory Multiple Myeloma

Key Points

Abstract

Citation Network

Connected Papers

Discussion

Authors

Journals

Actions

Institutions

References and Citations

Citation Network

Connected Papers

Discussion

Cite this study